Mealey's (December 3, 2018, 3:12 PM EST) -- WASHINGTON, D.C. — Contrary to a drug company’s assertion, a Second Circuit U.S. Court of Appeals’ decision affirming exclusion of a mother’s causation experts in her attempt to hold the drugmaker liable for her child’s birth defects “creates a wide divergence from other courts” and will have “a profound effect upon thousands of litigants,” making certiorari proper, the mother argues in her Nov. 27 reply brief to the U.S. Supreme Court (N.K. v. Abbott Laboratories, No. 18-327, U.S. Sup., 2018 U.S. S. Ct. Briefs LEXIS 4422)....